Default Category
-
Cancer Screening in Japan: Market Research and Segmentation
Quelch, John A.; Rodriguez, MargaretCase HBS-514057-EMarketingSince founding CancerScan in 2008, Jun Fukuyoshi and Yoshiki Ishikawa had helped to improve cancer screening rates in Japan. Between 2005 and 2007, awareness of breast cancer in Japan rose from 55% to 70%, but the incidence of breast cancer screenings remained constant. Jun and Yoshiki applied marketing research techniques to increase the screening rate for breast cancer, a disease which killed over 12,000 Japanese women in 2011. Cancer screening...Starting at €8.20
-
Vision 2020: Takeda and the Vaccine Business
Quelch, John A.; Rodriguez, MargaretCase HBS-514084-EMarketingTo maximize their effectiveness, color cases should be printed in color. In 2014, Yasuchika Hasegawa was orchestrating the transformation of Takeda from a Japanese pharmaceutical company with a global footprint into a global company with a Japanese heritage. A 33-year veteran of Takeda, Hasegawa-san was appointed president of Takeda in 2003 and chief executive in 2009. By 2013, Takeda was in the midst of implementing its new Vision 2020 plan, a s...Starting at €8.20
-
Wanxiang Group: A Chinese Company's Global Strategy (C)
Kirby, William C.; Wang, YuanzhuoCase HBS-318091-EThis case updates Wanxiang Group's activities since 2012, focusing on its electric vehicle strategy and a transition of the group's leadership.Starting at €5.74
-
Outrageous Ambition: Duke University
Kirby, William C.; Wang, YuanzhuoCase HBS-318043-EDuke University had grown from an one room school house in rural North Carolina in 1859 to one of the leading research universities in the U.S. and the world. Since the late 1950s, Duke's leaders had consciously used the process of strategic planning to guide the development of the university as a whole, building up programs in interdisciplinarity and initiating ambitious projects in internationalization. Under the leadership of President Richard...Starting at €8.20
-
Wenzhou Kangning Hospital: Changing Mental Healthcare in China
Kirby, William C.; Zhang, Wei; Wang, Yuanzhuo; Dai, Nancy HuaCase HBS-318054-EThe city of Wenzhou in the Province of Zhejiang, long known in China for entrepreneurship, now hosts the country's largest privately owned mental health hospital group. This case traces the development of Wenzhou Kangning Hospital Co, Ltd. from founding to just before its initial public offering to illustrate the extraordinary entrepreneurship happening in China's healthcare space. It highlights the challenges of China's mental health sector and ...Starting at €8.20
-
Wenzhou Kangning Hospital: Changing Mental Healthcare in China (B)
Kirby, William C.; Zhang, Wei; Wang, Yuanzhuo; Dai, Nancy HuaCase HBS-318077-EThis case updates Wenzhou Kangning Hospital Co, Ltd.'s activities since its IPO in late 2015, focusing on its strategy and growth since the IPO and challenges for the future.Starting at €5.74
-
HNA Group: Global Excellence with Chinese Characteristics (B)
Kirby, William C.; Wang, YuanzhuoCase HBS-318090-EKnowledge and CommunicationThis case provides a brief overview of the success and challenges of the HNA Group between 2015 and late 2017 when it grew rapidly through global acquisitions to became a Fortune 170 company. How would HNA face the challenges of being a truly global and prominent company in an era of increasing scrutiny of big businesses?Starting at €5.74
-
A Strait of Uncertainty: Taiwan's Development in the Shadow of China
Kirby, William C.; Greene, J. Megan; Manty, Tracy Yuen; Wang, YuanzhuoCase HBS-909408-ERelations between the People's Republic of China (PRC), on the Chinese Mainland, and the Republic of China (ROC), on Taiwan, had improved significantly since 2008. Taiwan investment in China had played a major role in China's economic boom in recent decades. Investments, partnerships, study, travel, and marriages across the Strait pointed to a future of ever-greater interaction between two parties that brought Asia to the brink of war three time...Starting at €8.20
-
GlaxoSmithKline in China (A)
Quelch, John A.; Rodriguez, MargaretCase HBS-514049-EMarketingFour GlaxoSmithKline employees were accused of bribing Chinese health care workers to prescribe the company's drugs. The accusations brought to light the questionable incentive structures of the Chinese health care system and the pressure on companies to adhere to local customs while still observing local laws.Starting at €8.20
-
GlaxoSmithKline in China (B)
Quelch, John A.; Rodriguez, MargaretCase HBS-514050-EMarketingIn 2013, Chinese investigators detained four GSK employees for allegedly bribing health care staff to sell GSK pharmaceuticals. A month later, GSK's Asia Pacific regional president, Abbas Hussain, said the company would help identify corrupt practices. Two days later, GSK's CEO, Andrew Witty, called the allegations "shameful" and said the company would use the opportunity to "make changes."Starting at €5.74